In contrast, PVT1 (Pan et al., 2018b; Derderian et al., 2019) and PANDAR (Li J. et al., 2017; Han et al., 2019) are well-known oncogenic lncRNAs, and their role in RCC tumorigenesis and negative impact on RCC outcome have been reported (Bao et al., 2017; Xu et al., 2017; Yang et al., 2017; Li et al., 2018). The gene discussed is PVT1; the disease is renal cell carcinoma.